Contact this trialFirst, we need to learn more about you.
DiviTum-TKa Assay for Breast Cancer
Recruiting1 award5 criteria
New Haven, Connecticut
This trial is testing a new method called DiviTum to see if it can help determine the right levels of medications for breast cancer patients. The trial will focus on patients with a specific type of breast
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service